RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020

Chawla, Rajeev; Madhu, Sri Venkata; Makkar, Brij; Ghosh, Sujoy; Saboo, Banshi; Kalra, Sanjay

doi:10.4103/ijem.ijem_225_20

Cited by 100 publications

(22 citation statements)

References 863 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The panel suggested HbA1c ≥6.5% as the optimal level for the diagnosis of diabetes in Indian patients and emphasized that HbA1c may be used in settings where an appropriate standardized method is available. [ 22 ]…”

Section: Q3: (A) What Are the Standard Diagnostic Criteria Of Diabetementioning

confidence: 99%

“…The current RSSDI-ESI joint clinical practice recommendations for the management of hypoglycemia are as follows. [ 22 ]…”

Section: Q5: How To Deal With Inadvertent Hypoglycemic Episodes In a mentioning

confidence: 99%

“…A thorough review of the patient's medical history should be undertaken, including the type of diabetes, duration of diabetes, presence of any complications, antidiabetic therapy, and concomitant drugs, including anticoagulant/antiplatelet drugs, antihypertensive drugs, or lipid-lowering drugs. [ 22 ] The patient should also be asked about how well their diabetes is controlled, how often they check blood sugars, and when was the last time their blood glucose level was checked and requesting the patient to bring a copy of the most recent HbA1c test. They should also be asked how often they see their doctor for their diabetes and when was the last visit for the same.…”

Section: Q7: What Suggestions Can Be Provided By a Diabetologist To Amentioning

confidence: 99%

“…To provide a perspective to the RSSDI-ESI clinical practice recommendations, it is necessary that for patients who are suspected to have prediabetes/diabetes or have diabetes or are newly diagnosed patients with diabetes, the dentist should collaborate with the consulting physician or a qualified expert for the medical management of diabetes during the planned dental procedure. [ 22 29 ] Patients who present to the dental clinic with an unknown status of diabetes but have risk factors for type 2 diabetes should be counseled for the same and referred to the physician for undertaking adequate screening, diagnosis, and management of diabetes.…”

Section: Q7: What Suggestions Can Be Provided By a Diabetologist To Amentioning

confidence: 99%

See 3 more Smart Citations

Management of periodontal disease in patients with diabetes- good clinical practice guidelines: A joint statement by Indian Society of Periodontology and Research Society for the Study of Diabetes in India

Jain¹,

Chawla

Kumar

et al. 2020

J Indian Soc Periodontol

Self Cite

View full text Add to dashboard Cite

Section: Q3: (A) What Are the Standard Diagnostic Criteria Of Diabetementioning

confidence: 99%

“…The current RSSDI-ESI joint clinical practice recommendations for the management of hypoglycemia are as follows. [ 22 ]…”

Section: Q5: How To Deal With Inadvertent Hypoglycemic Episodes In a mentioning

confidence: 99%

Section: Q7: What Suggestions Can Be Provided By a Diabetologist To Amentioning

confidence: 99%

Section: Q7: What Suggestions Can Be Provided By a Diabetologist To Amentioning

confidence: 99%

See 2 more Smart Citations

Management of periodontal disease in patients with diabetes- good clinical practice guidelines: A joint statement by Indian Society of Periodontology and Research Society for the Study of Diabetes in India

Jain¹,

Chawla

Kumar

et al. 2020

J Indian Soc Periodontol

Self Cite

View full text Add to dashboard Cite

“…Оцінку стану глюкозного гомеостазу здійснювали згідно рекомендацій RSSDI-ESI Consensus group 2020 р. [11]. Рівень глюкози в плазмі венозної крові визначали глюкозооксидазним методом на аналізаторі "Biosen C-line" (EKF, Німеччина).…”

Section: матеріали та методи дослідженняunclassified

Hyperuricemia as a Marker of Lipid Peroxidation Intensity in a Population

Chernyaieva

2020

Act. Probl. of the Modern Med.

View full text Add to dashboard Cite

The prevalence of hyperuricemia in the world has been steadily increasing over the past decade. According to various authors, the frequency of asymptomatic hyperuricemia in the population ranges from 5 to 35.1 per cent. The study of the relationship between purine metabolism disorders and the state of lipid peroxidation is still relevant due to numerous reports on the relationship between the processes of urate formation and free radical oxidation. Therefore, the aim of the study was to find out the value of hyperuricemia as a marker of the intensity of lipid peroxidation in a random population sample. Materials and methods. The group of participants was formed according to generally accepted epidemiological approaches using a random sample of workers and employees of an industrial enterprise (n=727 people, 457 men and 270 women, age ranged from 18 to 65 years, the average age was 38.13±5.10 years. Metabolic syndrome was diagnosed according to the recommendations of International Diabetes Federation, National Heart, Lung and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, and International Association for the Study of Obesity. Glucose homeostasis was evaluated according to the recommendations of the research society for the study of diabetes in India, Endocrine Society of India, 2020. Venous blood samples were taken on an empty stomach. We assessed the immunoreactive insulin content by immunochemiluminescent method, the concentration of triglycerides, cholesterol, high density lipoprotein by enzyme colorimetric method, xanthine and hypoxanthine were assessed by the method of S. V. Oreshnikov et al., uric acid was evaluated by colorimetric method, acylhydrazines – by the method of V. B. Gavrilov and M. I. Mishkorudny, malonic dialdehyde was assessed by the method of I. D. Steel, Garishvili T. G. in modification of L. I. Andreeva et al.; the level of total reduced SH groups was evaluated by the Elman photometric method, xanthine oxidase activity was studied by the photometric method, superoxide dismutase was examined by the T. V. Sirota method, and catalase in plasma and red blood cells – by the H. Aebi method. Results and discussion. Hyperuricemia was diagnosed in 118 (16.2%) patients. Violation of glucose homeostasis was diagnosed in 76 patients (10.5%): type 2 diabetes was found in 22 (3.03%) patients, glucose tolerance disorders were found in 47 (6.5%) patients, fasting hyperglycemia – in 7 (0, 96%), respectively. In a random population sample with hyperuricemia, the concentration of intermediate and final products of lipid peroxidation in the blood is significantly higher than in individuals with normouricemia. The concentration of reducing equivalents in the form of free SH groups does not significantly depend on the intensity of purine catabolism. The maximum intensity of lipid peroxidation is observed in the representatives of a random population sample with hyperuricemia in the presence of impaired glucose homeostasis. For this combination of pathological conditions, the concentrations of intermediate and final products of lipid peroxidation are significantly higher than for hyperuricemia by itself and hyperuricemia in combination with other components of the metabolic syndrome. The established links between disorders of purine metabolism and activation of lipid peroxidation demonstrate a close integration of purine metabolism pathology into hormonal and metabolic disorders of diabetogenic and atherogenic orientation at the level of a random population sample.

show abstract

One‐year trends from the LANDMARC trial: A 3‐year, pan‐India, prospective, longitudinal study on the management and real‐world outcomes of type 2 diabetes mellitus

Das

Kalra

Joshi

et al. 2021

Endocrino Diabet & Metabol

Self Cite

View full text Add to dashboard Cite

Introduction Longitudinal data on management and progression of type 2 diabetes mellitus (T2DM) in India are scarce. LANDMARC (CTRI/2017/05/008452), first‐of‐its‐kind, pan‐India, prospective, observational study aimed to evaluate real‐world patterns and management of T2DM over 3 years. Methods Adults (≥25 to ≤60 years old at T2DM diagnosis; diabetes duration ≥2 years at enrolment; controlled/uncontrolled on ≥2 anti‐diabetic agents) were enrolled. The first‐year trends for glycaemic control, therapy and diabetic complications, including those from metropolitan and non‐metropolitan cities are reported here. Results Of 6236 enrolled participants, 5654 completed 1 year in the study. Although the overall mean glycated haemoglobin (HbA1c) improved by 0.5% (baseline: 8.1%) at 1 year, only 20% of the participants achieved HbA1c <7%. Participants from metropolitan and non‐ metropolitan cities showed similar decrease in glycaemic levels (mean change in HbA1c: −0.5% vs. −0.5%; p = .8613). Among diabetic complications, neuropathy was the predominant complication (815/6236, 13.1% participants). Microvascular complications (neuropathy, nephropathy and retinopathy) were significantly (p < .0001) higher in non‐metropolitan than metropolitan cities. Hypertension (2623/6236, 78.2%) and dyslipidaemia (1696/6236, 50.6%) continued to be the most commonly reported cardiovascular risks at 1 year. After 1 year, majority of the participants were taking only oral anti‐diabetic drugs (OADs) (baseline: 4642/6236 [74.4%]; 1 year: 4045/6013 [67.3%]), while the proportion of those taking insulin along with OADs increased (baseline: 1498/6236 [24.0%] vs. 1 year: 1844/6013 [30.7%]). Biguanides and sulfonylureas were the most used OADs. The highest increase in use was seen for dipeptidyl peptidase‐IV inhibitors (baseline: 3047/6236 [48.9%]; 1 year: 3529/6013 [58.7%]). Improvement in all glycaemic parameters was significantly (p < .0001) higher in the insulin vs. the insulin‐naïve subgroups; in the insulin‐naïve subgroup, no statistical difference was noted in those who received >3 vs. ≤3 OADs. Conclusions First‐year trends of the LANDMARC study offer insights into real‐world disease progression, suggesting the need for controlling risk factors and timely treatment intensification in people with T2DM.

show abstract

RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020

Cited by 100 publications

References 863 publications

Management of periodontal disease in patients with diabetes- good clinical practice guidelines: A joint statement by Indian Society of Periodontology and Research Society for the Study of Diabetes in India

Management of periodontal disease in patients with diabetes- good clinical practice guidelines: A joint statement by Indian Society of Periodontology and Research Society for the Study of Diabetes in India

Hyperuricemia as a Marker of Lipid Peroxidation Intensity in a Population

One‐year trends from the LANDMARC trial: A 3‐year, pan‐India, prospective, longitudinal study on the management and real‐world outcomes of type 2 diabetes mellitus

Contact Info

Product

Resources

About